Published in Acta Endocrinol (Copenh) on December 01, 1989
Adjuvant treatment in breast cancer. Lancet (1992) 4.42
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
A radioimmunoassay for rat plasma ACTH. Endocrinology (1971) 3.35
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J (1973) 2.41
Adrenocorticotrophic action of long-acting tetracosactrin compared with corticotrophin-gel. Br Med J (1967) 2.39
A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab (1999) 2.30
Long-term treatment of acromegaly with bromocriptine. Br Med J (1977) 2.18
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) (1999) 2.15
Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf) (1997) 2.14
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine. Br Med J (1972) 2.07
[Changed diagnosis and treatment of hepatocellular carcinoma]. Ned Tijdschr Geneeskd (1996) 2.04
Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes. J Clin Oncol (1990) 2.02
Corticosteroid treatment and surgery. 1. An investigation of the indications for steroid cover. Anaesthesia (1969) 2.00
Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J (1974) 1.98
Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet (1980) 1.94
Cloning and characterization of cDNAs encoding human gastrin-releasing peptide. Proc Natl Acad Sci U S A (1984) 1.93
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93
Stereotactic radiosurgery at St. Bartholomew's hospital: third quinquennial review. Br J Radiol (2005) 1.91
Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol (Oxf) (2001) 1.89
Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) (1999) 1.85
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Bromocriptine treatment of acromegaly. Br Med J (1975) 1.70
Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) (1993) 1.69
Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res (1999) 1.69
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Ten different dietary fibers have significantly different effects on serum and liver lipids of cholesterol-fed rats. J Nutr (1994) 1.68
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. Br Med J (Clin Res Ed) (1983) 1.67
Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. Bone (2000) 1.66
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) (1986) 1.62
Apathetic T-3 toxicosis. Br Med J (1974) 1.61
The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. J Clin Endocrinol Metab (2000) 1.61
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet (1998) 1.59
An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) (1994) 1.59
A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr (2000) 1.56
Ectopic hormone production by non-endocrine tumours. Clin Endocrinol (Oxf) (1974) 1.56
Lung tumours and ACTH production. Clin Endocrinol (Oxf) (1977) 1.54
Pituitary tumours in the elderly: a 20 year experience. Eur J Endocrinol (1999) 1.54
Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab (2000) 1.52
Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med (1989) 1.52
Pituitary-adrenal function in severe depressive illness. Lancet (1968) 1.52
Danger lists for the anesthetist. Anaesthesia (1968) 1.52
Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest (1995) 1.49
Bromocriptine treatment of female infertility: report of 13 pregnancies. Br Med J (1975) 1.49
Letter: Metaclopramide and prolactin. Br Med J (1974) 1.48
Specificity of limited range of motion variable resistance training. Med Sci Sports Exerc (1989) 1.48
Immunoreactive corticotrophin levels in adrenocortical insufficiency. Br Med J (1971) 1.46
Stereotactic multiple arc radiotherapy. III--Influence of treatment of arteriovenous malformations on associated epilepsy. Br J Neurosurg (1997) 1.46
A reappraisal of human beta MSH. Nature (1974) 1.46
Plasma prolactin activity in inappropriate lactation. Br Med J (1971) 1.46
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study. Clin Endocrinol (Oxf) (2000) 1.45
An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clin Endocrinol (Oxf) (1997) 1.44
Cushing's syndrome. Clin Endocrinol Metab (1985) 1.44
Colorectal neoplasia in acromegaly. Gut (1999) 1.42
Lymphocytic hypophysitis: unusual features of a rare disorder. Clin Endocrinol (Oxf) (1995) 1.41
Radiotherapy for age-related macular degeneration. Clin Oncol (R Coll Radiol) (1998) 1.41
The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) (1985) 1.40
What is the optimal therapy of brain metastases? Clin Oncol (R Coll Radiol) (2001) 1.40
Late diagnosis of pituitary and parapituitary lesions causing visual failure. Br Med J (Clin Res Ed) (1986) 1.40
A comparison of conventional, conformal and intensity-modulated coplanar radiotherapy plans for posterior fossa treatment. Br J Radiol (2004) 1.39
The release of leptin and its effect on hormone release from human pituitary adenomas. Clin Endocrinol (Oxf) (2001) 1.39
Simultaneous breast cancer in non-identical Ashkenazi Jewish twins: management dilemmas when genetic testing is negative. Clin Oncol (R Coll Radiol) (2000) 1.39
Identification of olfactory dysfunction in carriers of X-linked Kallmann's syndrome. Clin Endocrinol (Oxf) (1994) 1.39
Pituitary peptide. Nat New Biol (1973) 1.39
Bilateral testicular tumours in congenital adrenal hyperplasia: a continuing diagnostic and therapeutic dilemma. Clin Endocrinol (Oxf) (1989) 1.38
The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab (1996) 1.38
Prolonged remission of lymphangitis carcinomatosis from breast cancer. Br J Dis Chest (1987) 1.38
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab (2001) 1.37
Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) (1982) 1.36
Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. Am Rev Respir Dis (1981) 1.35
Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Br J Ophthalmol (2009) 1.35
Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol (1996) 1.35
Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol (1986) 1.34
Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet (1995) 1.32
Prolactinomas. Br Med J (Clin Res Ed) (1985) 1.32
ACTH, lipotrophin and MSH in health and disease. Clin Endocrinol Metab (1977) 1.32
Cyclical combination chemotherapy and gonadal function. Retrospective study in males. Lancet (1979) 1.31
Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid. J Endocrinol (1980) 1.31